DSIP

DSIP, or Delta Sleep-Inducing Peptide, is a naturally occurring nonapeptide originally identified in mammalian brain tissue.

It is used as a neuropeptide research tool in preclinical studies of sleep regulation and neuroendocrine signaling.

Its very name — delta sleep-inducing peptide — has made it reputed in biohacking and recovery circles for supporting deep, restorative sleep and healthier sleep-wake regulation.

DSIP (delta sleep-inducing peptide) is popular in sleep-optimization and recovery communities for its purported role in improving deep sleep quality and normalizing disrupted sleep architecture. Researchers are investigating its interaction with circadian and stress-response systems, including effects on cortisol and the hypothalamic-pituitary axis, keywords common in discussions of sleep regulation and stress.

Biohackers anecdotally report smoother sleep onset and a sense of deeper recovery, framing it as a tool for managing stress load and supporting overnight repair. Preclinical studies also explore its possible influence on pain modulation and thermoregulation.

These are areas of active or preclinical investigation and community interest, not outcomes established in humans.

In animal-model research, investigators have measured DSIP in relation to slow-wave sleep patterns and hypothalamic-pituitary hormone modulation.

These findings reflect laboratory observations in animal models, not outcomes demonstrated in humans.

DSIP is provided in lyophilized form and stored at -20°C, sealed and shielded from light.

For research applications it is reconstituted using bacteriostatic or sterile water and kept at 4°C for near-term use or aliquoted at -80°C. Every lot is accompanied by an HPLC certificate of analysis.